Hegseth says "this is only just the beginning" of the Iran War

“We Must Leap Forward Into New Energy” - Canaccord’s Inaugural Nuclear Nexus Conference  A new report from Canaccord Genuity captures the main threads from the firm’s first Nuclear Nexus conference, where fission and fusion developers, academics, and investors gathered to confront the practical barriers to scaling nuclear power.  The event highlighted a shared recognition that surging electricity demand from AI data centers “finds itself bottle-necked by the physical reality of the grid”, forcing a hard look at fuel supply chains, regulatory timelines, and technology choices that can actually deliver power this...

Abivax Crashes Most On Record After Cancer Cases In Trial Data Spooks Wall Street French biotech Abivax suffered its largest intraday decline on record after reporting new data on its lead experimental inflammatory bowel disease drug, which showed cancer cases among patients in the clinical trial. The new data certainly point to regulatory headwinds and raise the risk profile for approval. Abivax's ABTECT maintenance data showed strong efficacy readout, with both once-daily obefazimod doses meeting the primary endpoint at week 44. Clinical remission rates were 50.8% for the 25 mg dose...

Tesla Weighs China Spinoff As Potential SpaceX Merger Looms Tesla is reportedly evaluating whether to separate its China operations through a sale, spinoff, or other restructuring as it considers a possible future merger with SpaceX, according to a new report from the Wall Street Journal. The discussions reflect increasing geopolitical tensions between the United States and China, as well as the unique regulatory challenges that would arise if Tesla became part of a company with significant U.S. defense contracts. The Journal reports that people familiar with the matter say Elon Musk has spent...